Basit öğe kaydını göster

dc.contributor.authorGÜRSU, Meltem
dc.contributor.authorOzturk, Savaş
dc.contributor.authorBehlul, Ahmet
dc.contributor.authorSumnu, Abdullah
dc.contributor.authorSakin, Abdullah
dc.contributor.authorSakin, Ayşegül
dc.contributor.authorSahin, Suleyman
dc.date.accessioned2021-03-08T12:59:00Z
dc.date.available2021-03-08T12:59:00Z
dc.date.issued2020
dc.identifier.citationSakin A., Sahin S., Behlul A., Sumnu A., GÜRSU M., Sakin A., Ozturk S., "The association of Visfatin levels with metabolic parameters and inflammation in diabetic nephropathy", Eastern Journal of Medicine, cilt.25, sa.2, ss.218-224, 2020
dc.identifier.othervv_1032021
dc.identifier.otherav_2c80179a-ca77-4907-a4af-a93dafbae644
dc.identifier.urihttp://hdl.handle.net/20.500.12627/167619
dc.identifier.urihttps://avesis.istanbul.edu.tr/api/publication/2c80179a-ca77-4907-a4af-a93dafbae644/file
dc.identifier.urihttps://doi.org/10.5505/ejm.2020.27122
dc.description.abstract© 2020, Yuzuncu Yil Universitesi Tip Fakultesi. All rights reserved.To investigate the visfatin levels at the stages of diabetic nephropathy(DNP), changes in visfatin levels according to stages of DNP, and the association of visfatin levels with other anti-inflammatory parameters including high sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), and tumor necrosis factor alpha(TNFα). Patients were divided into 4 groups based on the glomerular filtration rate (GFR) and albuminuria as follows; Group I: Albuminuria60ml/min, Group II:albuminuria 30 to 300 mg per day and GFR>60ml/min, Group III:albuminuria>300mg per day and GFR>60ml/min, and Group IV: Albuminuria>300 mg per day and GFR<60 ml/min. Of the 141 patients included in the study, 83(58.8%) were female. The mean age of patients was 55.3±8.2 years. Microalbuminuria was found to be 10.1±9.8 mg per day in group I, 89.4±68.2 mg per day in group II, 525.1±280.7 mg per day in group III, and 1034±1893 mg per day in group IV (p<0.001). When the correlation analysis was repeated separately in each group, there was a positive correlation between Visfatin and IL-6 levels in only group III (r=0.926; p<0.001). When the patients in group III and IV were combined in a single group and considered as macro-albuminuric, multivariate analysis showed that visfatin had a positive correlation with IL-6 (r=0.380, p=0.006) In this study, we could not determine any association between visfatin levels and other anti-inflammatory markers (IL-6, TNFα, and hsCRP). However, we found a close relationship between visfatin levels and IL-6 which is one of the most important markers of inflammation in diabetic patients with overt nephropathy, namely macro-albuminuric patients.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectHealth Sciences
dc.subjectTemel Tıp Bilimleri
dc.subjectGeneral Medicine
dc.subjectTıp
dc.subjectTIP, GENEL & İÇECEK
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.titleThe association of Visfatin levels with metabolic parameters and inflammation in diabetic nephropathy
dc.typeMakale
dc.relation.journalEastern Journal of Medicine
dc.contributor.departmentUniversity of Health Sciences , ,
dc.identifier.volume25
dc.identifier.issue2
dc.identifier.startpage218
dc.identifier.endpage224
dc.contributor.firstauthorID2528695


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster